Shockwave Medical, Inc.
SWAV
$330.49
$0.490.15%
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 7.80% | 9.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.80% | 9.12% | |||
| Cost of Revenue | 11.42% | 3.28% | |||
| Gross Profit | 7.28% | 10.00% | |||
| SG&A Expenses | 14.28% | 16.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.36% | 11.79% | |||
| Operating Income | -4.88% | 0.58% | |||
| Income Before Tax | -9.85% | 23.03% | |||
| Income Tax Expenses | -147.93% | 10.51% | |||
| Earnings from Continuing Operations | 24.92% | 26.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.92% | 26.64% | |||
| EBIT | -4.88% | 0.58% | |||
| EBITDA | -4.49% | 0.69% | |||
| EPS Basic | 23.73% | 26.18% | |||
| Normalized Basic EPS | -12.75% | 23.53% | |||
| EPS Diluted | 24.89% | 25.33% | |||
| Normalized Diluted EPS | -12.63% | 24.11% | |||
| Average Basic Shares Outstanding | 0.96% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.82% | -0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
